Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Peyruchaud

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal De La Societe De Biologie|December 25, 2007
[Mechanisms of bone metastasis formation]Olivier Peyruchaud
Anti-Cancer Agents in Medicinal Chemistry|May 16, 2009
Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancerOlivier Peyruchaud
Journal of Bone Oncology|October 21, 2016
The role of platelets and megakaryocytes in bone metastasisRaphael Leblanc, Olivier Peyruchaud
Experimental Cell Research|December 3, 2014
New insights into the autotaxin/LPA axis in cancer development and metastasisRaphaël Leblanc, Olivier Peyruchaud
Blood|May 8, 2016
Metastasis: new functional implications of platelets and megakaryocytesRaphael Leblanc, Olivier Peyruchaud
British Journal of Pharmacology|February 2, 2021
Emerging role of cysteinyl LTs in cancerLou Saier, Olivier Peyruchaud
Cancers|January 8, 2020
Autotaxin Implication in Cancer Metastasis and Autoimunne Disorders: Functional Implication of Binding Autotaxin to the Cell SurfaceOlivier Peyruchaud, Lou Saier, Raphaël Leblanc
British Journal of Pharmacology|May 20, 2018
Platelets, autotaxin and lysophosphatidic acid signalling: win-win factors for cancer metastasisRaphael Leblanc, Audrey Houssin, Olivier Peyruchaud
Biochimica Et Biophysica Acta|June 20, 2012
Pleiotropic activity of lysophosphatidic acid in bone metastasisOlivier Peyruchaud, Raphael Leblanc, Marion David
Frontiers in Immunology|April 20, 2019
Osteoimmunology of Bone Loss in Inflammatory Rheumatic DiseasesFabienne Coury, Olivier Peyruchaud, Irma Machuca-Gayet
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal De La Societe De Biologie|December 25, 2007
[Mechanisms of bone metastasis formation]Olivier Peyruchaud
Anti-Cancer Agents in Medicinal Chemistry|May 16, 2009
Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancerOlivier Peyruchaud
Journal of Bone Oncology|October 21, 2016
The role of platelets and megakaryocytes in bone metastasisRaphael Leblanc, Olivier Peyruchaud
Experimental Cell Research|December 3, 2014
New insights into the autotaxin/LPA axis in cancer development and metastasisRaphaël Leblanc, Olivier Peyruchaud
Blood|May 8, 2016
Metastasis: new functional implications of platelets and megakaryocytesRaphael Leblanc, Olivier Peyruchaud
British Journal of Pharmacology|February 2, 2021
Emerging role of cysteinyl LTs in cancerLou Saier, Olivier Peyruchaud
Cancers|January 8, 2020
Autotaxin Implication in Cancer Metastasis and Autoimunne Disorders: Functional Implication of Binding Autotaxin to the Cell SurfaceOlivier Peyruchaud, Lou Saier, Raphaël Leblanc
British Journal of Pharmacology|May 20, 2018
Platelets, autotaxin and lysophosphatidic acid signalling: win-win factors for cancer metastasisRaphael Leblanc, Audrey Houssin, Olivier Peyruchaud
Biochimica Et Biophysica Acta|June 20, 2012
Pleiotropic activity of lysophosphatidic acid in bone metastasisOlivier Peyruchaud, Raphael Leblanc, Marion David
Frontiers in Immunology|April 20, 2019
Osteoimmunology of Bone Loss in Inflammatory Rheumatic DiseasesFabienne Coury, Olivier Peyruchaud, Irma Machuca-Gayet
Pageof 5